切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2017, Vol. 10 ›› Issue (05) : 597 -600. doi: 10.3877/cma.j.issn.1674-6902.2017.05.027

所属专题: 文献

综述

哮喘-慢性阻塞性肺疾病重叠的诊疗进展
李瑞丽1, 华毛2,(), 冯喜英2, 马维秀2, 李寒1   
  1. 1. 810001 西宁,青海大学研究生院
    2. 810001 西宁,青海大学附属医院呼吸内科
  • 收稿日期:2017-05-22 出版日期:2017-10-20
  • 通信作者: 华毛

Progress in diagnosis and treatment of overlap between asthma and chronic obstructive pulmonary disease

Ruili Li1, Mao Hua2(), Xiying Feng2   

  • Received:2017-05-22 Published:2017-10-20
  • Corresponding author: Mao Hua
引用本文:

李瑞丽, 华毛, 冯喜英, 马维秀, 李寒. 哮喘-慢性阻塞性肺疾病重叠的诊疗进展[J/OL]. 中华肺部疾病杂志(电子版), 2017, 10(05): 597-600.

Ruili Li, Mao Hua, Xiying Feng. Progress in diagnosis and treatment of overlap between asthma and chronic obstructive pulmonary disease[J/OL]. Chinese Journal of Lung Diseases(Electronic Edition), 2017, 10(05): 597-600.

1
朱燕亭,宋旸,李少军,等. 哮喘与慢性阻塞性肺疾病重叠综合征的研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(3): 377-379.
2
李超,方圆,李志奎. 哮喘-COPD重叠综合症相关性疾病166例分析[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(6): 704-709.
3
颜文杰,宋勇. 哮喘-慢性阻塞性肺疾病重叠综合征研究的进展[J/CD]. 中华肺部疾病杂志(电子版), 2017, 10(3): 356-357.
4
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease ( Updated 2014 ) .

URL    
5
Global strategy for asthma management and prevention 2014(revision).

URL    
6
Global Strategy for the Diagnosis, Management and Prevention of COPD,Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2015

URL    
7
Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2017. Vancouver, USA GINA; 2017.
8
Menezes AMB, Montes de Oca M, Pérez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype:COPDAsthma[J]. Chest, 2014, 145(2): 297-304.
9
Postma DS, Rabe KF. The Asthma-COPD Overlap Syndrome[J]. N Engl J Med, 2015, 373(13): 1241-1249.
10
Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD:what are its features and how important is it? [J]. Thorax, 2009, 64(8): 728-735.
11
Hakonarson H, Carter C, Kim C, et al. Altered expression and action of the low-affinity IgE receptor FcepsilonRII (CD23) in asthmatic airway smooth muscle[J]. J Allergy Clin Immunol, 1999, 104(1): 575-584.
12
Postma DS, Rabe KF. The asthma-COPD overlap syndrome[J]. N Engl J Med, 2015, 373(13): 1241-1249.
13
Gelb AF, Yamamoto A, Verbeken EK, et al. Unraveling the pathophysiology of the asthma-COPD overlap syndrome: un-suspected mild centrilobular emphysema Is responsible for loss of lung elastic recoil in never smokers with asthma with persistent expiratory airflow limitation[J]. Chest, 2015, 148(2): 313-320.
14
Christenson SA, Steiling K, van den Berge M, et al. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2015, 191(7): 758-766.
15
Hardin M, Cho M, McDonald ML, et al. The clinical and genetic features of COPD-asthma overlap syndrome[J]. Eur Respir J, 2014, 44(2): 341-350.
16
Smolonska J, Koppelman GH, Wijmenga C, et al. Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis[J]. Eur Respir J, 2014, 44(4): 860-872.
17
McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease[J]. N Engl J Med, 2011, 365(17): 1567-1575.
18
Sunil VR, Patel KJ, Mainelis G, et al. Pulmonary effects of inhaled diesel exhaust in aged mice[J]. Toxicol Appl Pharmacol, 2009, 241(3): 283-293.
19
Erzurum SC. New Insights in Oxidant Biology in Asthma[J]. Ann Am Thorac Soc, 2016, 13(Suppl 1): S35-S39.
20
Kalinina EP, Denisenko YK, Vitkina TI, et al. The Mechanisms of the Regulation of Immune Response in Patients with Comorbidity of Chronic Obstructive Pulmonary Disease and Asthma[J]. Can Respir J, 2016, 2016(6): 1-8.
21
Kobayashi S, Hanagama M, Yamanda S, et al. Inflammatory biomarkers in asthma-COPD overlap syndrome[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11(1): 2117-2123.
22
Brzostek D, Kokot M. Asthma-chronic obstructive pulmonary disease overlap syndrome in Poland. Findings of an epidemiological study [J]. Postepy Dermatol Alergol, 2014, 31(6): 372-379.
23
Chung WS, Lin CL, Kao CH. Comparison of Acute Respiratory Events between Asthma-COPD Overlap Syndrome and COPD Patients: A Population-Based Cohort Study[J]. Medicine (Baltimore), 2015, 94(17): e755.
24
Yeh JJ, Wang YC, Kao CH. Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome Associated with Risk of Pulmonary Embolism[J]. PLoS One, 2016, 11(9): e0162483.
25
Yeh JJ, Wang YC, Kao CH. Asthma-Chronic Obstructive Pulmonary Diseases Overlap Syndrome Increases the Risk of Incident Tuberculosis: A National Cohort Study[J]. Plos One, 2016, 11(7): e0159012.
26
Soler-Cataluña JJ, Cosío B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD[J]. Arch Bronconeumol, 2012, 48(9): 331-337.
27
Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). Updated 2016.

URL    
28
Cheng SL, Lin CH. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11(1): 2341-2348.
29
Castiglia D, Battaglia S, Benfante A, et al. Pharmacological management of elderly patients with asthma-chronic obstructive pulmonary disease overlap syn-drome: room for speculation?[J]. Drugs Aging, 2016, 33(6):375-385.
30
Lapperre TS, Snoeck-Stroband JB, Gosman MM, et al. Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial[J]. Ann Intern Med, 2009, 151(8): 517-527.
31
Antoniu SA. Targeting 5-lipoxygenase-activating protein in asthma and chronic obstructive pulmonary disease[J]. Expert Opin Ther Targets, 2014, 18(11): 1285-1292.
32
Nakawah MO, Hawkins C, Barbandi F. Asthma, Chronic Obstructive Pulmonary Disease (COPD), and the Overlap Syndrome[J]. J Am Board Fam Med, 2013, 26(4): 470-477.
33
Louie S, Zeki AA, Schivo M, et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations[J]. Expert Rev Clin Pharmacol, 2013, 6(2): 197-219.
34
Ding B, Enstone A. Asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): structured literature review and physician insights[J]. Expert Rev Respir Med, 2016, 10(3): 363-371.
35
Segreti A, Stirpe E, Rogliani P, et al. Defining phenotypes in COPD: anaid to personalized healthcare[J]. Mol Diagn Ther, 2014, 18(4): 381-388.
[1] 马锦芳, 何正光, 郑劲平. 盐酸氨溴索雾化吸入治疗慢性阻塞性肺疾病黏痰症患者的疗效和安全性分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 568-574.
[2] 程炜炜, 张青, 张诚实, 冯契靓, 陈荣荣, 赵云峰. 全身免疫炎症指数与慢性阻塞性肺疾病急性加重期病情严重程度相关性分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 580-584.
[3] 杨万荣, 任治坤, 时新颍. 沙丁胺醇雾化吸入脾多肽治疗AECOPD的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 609-612.
[4] 赖乾德, 吕相琴, 蔺洋, 刘媛梅, 赵春艳, 李琦. 肝素结合蛋白对慢性阻塞性肺疾病预后预测分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 613-616.
[5] 王微, 丁霖, 陈茜, 呼延欣, 闫蓓. 综合治疗对慢性阻塞性肺疾病的疗效及转归影响分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 621-624.
[6] 方晓玉, 王婷, 赵珊, 陈锋. HALP指数对AECOPD并发呼吸衰竭患者ICU结局的预测意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 639-641.
[7] 郭少琳, 郭建英, 左秀萍, 高苗. 慢性阻塞性肺疾病康复训练依从性影响因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 652-654.
[8] 白若靖, 郭军. 维生素D对肺部疾病临床意义的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 659-662.
[9] 杨坤, 赵景成, 吴永强. 无创呼吸机在慢性阻塞性肺疾病并发呼吸衰竭救治的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 481-483.
[10] 孔令梅, 徐晓媛, 马丽颖. 慢性阻塞性肺疾病认知衰弱危险因素及预后分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 407-410.
[11] 徐艳, 江秀娟, 王超, 江圆满. 股直肌剪切波弹性成像对COPD并发肌少症的诊断意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 454-457.
[12] 黄映兰, 骆丽萍, 郭慧玲, 袁麟标. 慢性阻塞性肺疾病糖皮质激素治疗反应性的影响因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 469-471.
[13] 宋素莉, 贺英华, 陈丽娟. COPD并发吸入性CAP危险因素及病原菌分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(02): 264-267.
[14] 陈婷婷, 李春娟. 经鼻高流量湿化氧疗治疗AECOPD伴Ⅱ型呼吸衰竭的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(02): 276-279.
[15] 周文欢, 杨黎. AECOPD低钠血症发生风险及预测因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(02): 313-315.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?